Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
JrhFY3SGEcAkU7rg
Écouter
Français